相关实验视频

Updated: Aug 8, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.0K

一个分子动力学模拟分析使用生物信息学方法对COVID-19药物重新定位的分析

Shahid Ullah1, Wajeeha Rahman1, Farhan Ullah1

  • 1S Khan Lab Mardan, Khyber Pakhtunkhwa, Pakistan.

Journal of biomolecular structure & dynamics
|October 26, 2023
PubMed
概括

研究人员确定了两种FDA批准的药物,可以抑制SARS-CoV-2主要蛋白酶 (6lu7). 这种药物重新定位加速了COVID-19治疗的新药开发.

关键词:
在 COVID-19 疫情中,药物重用是为了改变药物的用途.主要蛋白质酶的主要蛋白质酶分子动力学模拟模拟虚拟选 虚拟选 虚拟选

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

237
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...